Peter Lynch fit · Growth at a reasonable price (GARP)
Is Twist Bioscience Corporation (TWST) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
45/100
DNot a fit
2/6 criteria passed
Peter Lynch's Criteria, Applied to TWST
PEG ≤ 1.0
key-
EPS CAGR ≥ 15%
key-
Revenue CAGR ≥ 10%
29.9%
Net margin > 0
-19.8%
Manageable debt (D/E < 1)
0.2x
Positive free cash flow
No
How TWST Scores on Other Strategies
Live Financial Snapshot
Market cap
$4.16B
P/E (TTM)
-
ROIC (TTM)
-24.5%
Gross margin
52.07%
Other Peter Lynch fit reports
Frequently Asked Questions
What is TWST's Peter Lynch fit score?
TWST scores 45/100 on our Peter Lynch fit engine - grade D. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own TWST?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends TWST.
How often is this score updated?
TWST's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends TWST.